Relevant bibliographies by topics / Prostate – Cancer – Diagnostic

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Prostate – Cancer – Diagnostic'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 June 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Prostate – Cancer – Diagnostic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Prostate – Cancer – Diagnostic"

1

Nomani, Beenish Hussain, and Mohiuddin Alamgir. "Diagnostic Utility Of Various Biomarkers For Prostate Cancer: A Review." Journal of Bahria University Medical and Dental College 09, no. 02 (2019): 151–55. http://dx.doi.org/10.51985/jbumdc2019015.

Full text
Abstract:
Prostate carcinoma is one of the most widespread occurring cancers in males and is the second most common cause of cancer related mortality in men around the world. The therapeutic success rate for prostate cancer can be greatly improved if the disease is detected at an early stage. Therefore, a successful therapy depends immensely on the clinical indicators (biomarkers) for early diagnosis and progression of the disease, as well as the prognosis after the clinical intervention. Despite of its limitations, prostate biopsy is the “gold standard” for diagnosis of prostatic carcinoma. Beyond the
APA, Harvard, Vancouver, ISO, and other styles
2

Sedláčková, Hana, Olga Dolejšová, Milan Hora, et al. "Prostate Cancer Diagnostic Algorithm as a “Road Map” from the First Stratification of the Patient to the Final Treatment Decision." Life 11, no. 4 (2021): 324. http://dx.doi.org/10.3390/life11040324.

Full text
Abstract:
The diagnostics of prostate cancer are currently based on three pillars: prostate biomarker panel, imaging techniques, and histological verification. This paper presents a diagnostic algorithm that can serve as a “road map”: from initial patient stratification to the final decision regarding treatment. The algorithm is based on a review of the current literature combined with our own experience. Diagnostic algorithms are a feature of an advanced healthcare system in which all steps are consciously coordinated and optimized to ensure the proper individualization of the treatment process. The pr
APA, Harvard, Vancouver, ISO, and other styles
3

Cherkasova, Zh R., S. A. Tsurkan, A. I. Prostyakova, et al. "Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen." Research and Practical Medicine Journal 10, no. 1 (2023): 10–26. http://dx.doi.org/10.17709/2410-1893-2023-10-1-1.

Full text
Abstract:
Purpose of the study. Evaluation of the diagnostic characteristics of the CA‑62 marker for epithelial carcinomas for detecting early‑stage prostate cancer in a double‑blind clinical study. This study is also focused on the possibility of using the CA‑62 antigen as an auxiliary tool for decision‑making in prostate cancer diagnosis.Patients and methods. A blinded clinical study was conducted on 325 clinically verified blood serum samples. This includes 144 prostate cancer samples, 79 generally healthy volunteers‑men and 102 samples from patients with benign prostatic hyperplasia (BPH). Quantitat
APA, Harvard, Vancouver, ISO, and other styles
4

Tribian, L. S., M. Lennartz, N. C. Blessin, et al. "Diagnostic role and prognostic impact of PSAP immunohistochemistry: A tissue microarray study on 31,358 cancer tissues from 127 different tumor types." American Journal of Clinical Pathology 160, Supplement_1 (2023): S47—S48. http://dx.doi.org/10.1093/ajcp/aqad150.107.

Full text
Abstract:
Abstract Introduction/Objective Prostatic specific acid phosphatase (PSAP) protein is produced in prostate epithelial cells and it is used as an immunohistochemical marker for prostate cancer. However, studies have reported PSAP expression to occur in various other tumor entities as well. Methods/Case Report Prostatic specific acid phosphatase (PSAP) protein is produced in prostate epithelial cells and it is used as an immunohistochemical marker for prostate cancer. However, studies have reported PSAP expression to occur in various other tumor entities as well. Results (if a Case Study enter N
APA, Harvard, Vancouver, ISO, and other styles
5

Tribian, Laura Sophie, Maximilian Lennartz, Doris Höflmayer, et al. "Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues." Diagnostics 13, no. 20 (2023): 3242. http://dx.doi.org/10.3390/diagnostics13203242.

Full text
Abstract:
Prostate-specific acid phosphatase (PSAP) is a marker for prostate cancer. To assess the specificity and prognostic impact of PSAP, 14,137 samples from 127 different tumor (sub)types, 17,747 prostate cancers, and 76 different normal tissue types were analyzed via immunohistochemistry in a tissue microarray format. In normal tissues, PSAP staining was limited to the prostate epithelial cells. In prostate cancers, PSAP was seen in 100% of Gleason 3 + 3, 95.5% of Gleason 4 + 4, 93.8% of recurrent cancer under androgen deprivation therapy, 91.0% of Gleason 5 + 5, and 31.2% of small cell neuroendoc
APA, Harvard, Vancouver, ISO, and other styles
6

Dolgushin, M. B., N. A. Meshcheryakova, A. A. Odzharova, et al. "18F-PSMA-1007 POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF RECURRENT PROSTATE CANCER: CLINICAL OBSERVATION." Cancer Urology 14, no. 3 (2018): 134–38. http://dx.doi.org/10.17650/1726-9776-2018-14-3-134-138.

Full text
Abstract:
Objective: demonstration of possibilities of18F-prostate specific membrane antigen-1007 (18F-PSMA-1007) positron emission tomography/computed tomography (PET/CT) for diagnostic prostate cancer recurrence.The article presents clinical observation of the patient with prostate cancer biochemical recurrence after the multiple treatment.18F-PSMA-1007 PET/CT demonstrates high sensitivity in prostate cancer recurrence diagnostic, in particular with low prostatic specific antigen level.
APA, Harvard, Vancouver, ISO, and other styles
7

Viehweger, F., M. Lennartz, N. C. Blessin, et al. "Prostein expression in human tumors: A tissue microarray study on 19,202 tumors." American Journal of Clinical Pathology 160, Supplement_1 (2023): S45. http://dx.doi.org/10.1093/ajcp/aqad150.101.

Full text
Abstract:
Abstract Introduction/Objective Prostein (P501S), also termed solute carrier family 45 member 3 (SLC45A3) is an androgen regulated protein which is preferentially expressed in prostate epithelial cells. Because of its frequent expression in prostate cancer, prostein was suggested a diagnostic prostate cancer marker. Methods/Case Report In order to comprehensively assess the diagnostic utility of prostein immunohistochemistry, a tissue microarray containing 19,202 samples from 152 different tumor types and subtypes as well as 608 samples of 76 different normal tissue types was analyzed by immun
APA, Harvard, Vancouver, ISO, and other styles
8

Mahaveer Chand, Nischal, Poornima K. Tekumalla, Matt T. Rosenberg, et al. "Filamin A Is a Prognostic Serum Biomarker for Differentiating Benign Prostatic Hyperplasia from Prostate Cancer in Caucasian and African American Men." Cancers 16, no. 4 (2024): 712. http://dx.doi.org/10.3390/cancers16040712.

Full text
Abstract:
Prostate cancer represents a significant health risk to aging men, in which diagnostic challenges to the identification of aggressive cancers remain unmet. Prostate cancer screening is driven by the prostate-specific antigen (PSA); however, in men with benign prostatic hyperplasia (BPH) due to an enlarged prostate and elevated PSA, PSA’s screening utility is diminished, resulting in many unnecessary biopsies. To address this issue, we previously identified a cleaved fragment of Filamin A (FLNA) protein (as measured with IP-MRM mass spectrometry assessment as a prognostic biomarker for stratify
APA, Harvard, Vancouver, ISO, and other styles
9

Dülgeroğlu, Yakup, Gönül Erden, Musa Ekici, et al. "Diagnostic efficiency of miR-21 and miR-34a serum levels in malign and benign prostate diseases." Yeni Üroloji Dergisi 16, no. 3 (2021): 221–27. http://dx.doi.org/10.33719/yud.2021;16-3-865045.

Full text
Abstract:
Objective: In this study aimed to determine the diagnostic efficiency of miR-21 and miR-34a serum levels in the discrimination of benign prostatic hyperplasia, chronic prostatitis, and prostate cancer. Materials and Methods: Blood samples were taken from 70 patients (25 benign prostatic hyperplasias, 10 chronic prostatitides, and 35 prostate cancer) who underwent prostate needle biopsy. After obtaining serum under suitable conditions, RNA isolation, cDNA synthesis, and qRT-PCR analysis were performed using Qiagen brand kits on Rotor-Gene® Q (Qiagen, Germany) device. -∆Ct values ​​were calculat
APA, Harvard, Vancouver, ISO, and other styles
10

Leonova, A. O., E. I. Kopyltsov, B. Ya Alekseev, et al. "Medical, social, and economic perspectives of health care development. Prostate Cancer Early Diagnosis and Screening Program." Cancer Urology 18, no. 2 (2022): 217–25. http://dx.doi.org/10.17650/1726-9776-2022-18-2-217-225.

Full text
Abstract:
Aim. To improve diagnostics and screening of prostate cancer to ensure early detection of malignant tumors.Materials and methods. We analyzed the population size and structure in the region in 2005–2010. The primary diagnostics of prostate cancer in regional healthcare institutions allowed the detection of locally advanced tumors and generalized cancer. Such diagnostic approaches can produce only accidental diagnosis since they lack proper systematization, organization, and control.Results. We have developed and implemented into clinical practice a long-term Program for Prostate Cancer Early D
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Prostate – Cancer – Diagnostic"

1

Savet, Sandrine. "Antigène spécifique de la prostate (PSA) : intérêt clinique actuel de son dosage sérique dans les affections prostatiques." Paris 5, 1998. http://www.theses.fr/1998PA05P132.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

FILLOUX, MORFAUX VIRGINIE. "Apport de l'echographie endorectale dans le diagnostic du cancer de la prostate." Amiens, 1989. http://www.theses.fr/1989AMIEM143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wall, David P. "Responding to localised prostate cancer : Lifeworld reconstruction during the first post-diagnostic year." Thesis, Edith Cowan University, Research Online, Perth, Western Australia, 2005. https://ro.ecu.edu.au/theses/655.

Full text
Abstract:
This thesis investigated the experiences of men diagnosed with localised prostate cancer, as they reconstructed their lifeworlds during the first post-diagnostic year. With the exception of health related quality of life, a review of the psychosocial research literature revealed few studies that, explored the psychosocial experience of men diagnosed with localised prostate cancer. Furthermore, the review uncovered no studies that explored the process of Iifeworld reconstruction, and only three studies that considered the role of masculinity in the responses of men to the prostate cancer experi
APA, Harvard, Vancouver, ISO, and other styles
4

Piaton, Eric. "Place de la cytologie dans l'évaluation diagnostique et pronostique de la glande prostatique." Lyon 1, 1990. http://www.theses.fr/1990LYO1T234.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Willaume, Philippe. "Apport de l'echographie endorectale au diagnostic du cancer prostatique : a propos de 936 echographies endorectales." Lille 2, 1990. http://www.theses.fr/1990LIL2M103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Abdullah, Gadija. "Functional analysis of miRNA regulated genes in prostate cancer as potential diagnostic molecules." University of the Western Cape, 2016. http://hdl.handle.net/11394/5648.

Full text
Abstract:
>Magister Scientiae - MSc<br>Prostate Cancer is the leading cause of cancer-related death in males in the Western world. It is a common biological disease originating from the reproductive system of the male namely, the prostate gland, usually in older patients (over the age of 50) and with a family history of this disease. The disease shows clinical aggressiveness due to genetic alterations of gene expression in prostate epithelial cells. Prostate cancer is currently diagnosed by biopsy and prostate cancer screening via the Prostate-Specific Antigen (PSA) blood test. Early detection is criti
APA, Harvard, Vancouver, ISO, and other styles
7

Durand, Matthieu. "Imagerie expérimentale ex vivo de haute résolution à 7 tesla du cancer localisé de la prostate." Thesis, Lille 2, 2019. http://www.theses.fr/2019LIL2S015/document.

Full text
Abstract:
L’IRM à 1,5T ou 3T de la prostate est l’imagerie la plus performante pour la détection du cancer de prostate. Nous avons travaillé à des modèles expérimentaux ex vivo d’IRM haute résolution à 7T permettant d’améliorer la résolution spatiale et la détection tumorale.La première partie de ce travail a porté sur la mise au point de protocoles d’analyse IRM de tissus prostatiques ex vivo à 7T. Des coupes de tissus de pièces opératoires et cadavériques avec et sans cancer ont été étudiées. Les données obtenues ont permis de définir des paramètres de séquence en turbo spin-echo pour obtenir des imag
APA, Harvard, Vancouver, ISO, and other styles
8

Adamo, Hanibal Hani. "TINT Tumor Indicating Normal Tissue : new field of diagnostic biomarkers for prostate cancer." Doctoral thesis, Umeå universitet, Institutionen för medicinsk biovetenskap, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-119706.

Full text
Abstract:
Background: Prostate cancer is the most common cancer in Sweden. Due its highly variable behavior, multifocal nature, and insufficient diagnostic methods, prostate cancer is difficult to diagnose and prognosticate. Some patients have an aggressive lethal disease, but the majority of prostate cancer patients have slow-growing, non-lethal disease with long expected survival without treatment. Current diagnostic methods―serum levels of prostate-specific antigen (PSA) and histological grading of biopsied prostate tissue―often do not give the information required to be able to safely differentiate
APA, Harvard, Vancouver, ISO, and other styles
9

PALENC, JEAN-MICHEL. "Apport de l'echographie transrectale et de la biopsie transrectale dans le diagnostic du cancer prostatique." Toulouse 3, 1991. http://www.theses.fr/1991TOU31083.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Forno, I. "EXPRESSION ANALYSIS OF MICRORNA IN PROSTATE CANCER AND IDENTIFICATION OF NOVEL DIAGNOSTIC BIOMARKER." Doctoral thesis, Università degli Studi di Milano, 2014. http://hdl.handle.net/2434/231097.

Full text
Abstract:
Introduzione: Il tumore alla prostata (PCa) è una delle neoplasie più comuni tra gli uomini nel mondo occidentale e, globalmente, rappresenta la sesta causa di morte dovuta a cancro. L'approccio diagnostico attuale si basa sulla misurazione dei livelli sierici dell’antigene prostatico PSA (prostate specific antigen), nonostante recenti studi clinici abbiano dimostrato che questo marcatore non riduce significativamente la mortalità associata a PCa. In questo scenario abbiamo ipotizzato che i microRNA possano essere nuovi potenziali biomarcatori di PCa. Scopo del lavoro: L'identificazione di mi
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Prostate – Cancer – Diagnostic"

1

Hedvig, Hricak, and Scardino Peter T, eds. Prostate cancer. Cambridge University Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

J, Russell Pamela, Jackson Paul 1961-, and Kingsley Elizabeth A, eds. Prostate cancer methods and protocols. Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

A, Saylor Jake, and Michaels Lionel B, eds. PSA and prostate cancer. Nova Science Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schatten, Heide, ed. Molecular & Diagnostic Imaging in Prostate Cancer. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-99286-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wernert, Nicholas. Immunhistochemie der Prostata und des Prostatakarzinoms: Neue Aspekte der Histogenese = Immunohistochemistry of the prostate and prostate carcinoma : new aspects of histogenesis. Fischer, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

K, Brawer Michael, ed. Prostate specific antigen. Marcel Dekker, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1937-, Labrie Fernand, Lee Fred 1930-, and Dupont André Ph D, eds. Early stage prostate cancer: Diagnosis and choice of therapy : proceedings of the International Symposium on Diagnosis and Treatment of Early Stage Prostate Cancer, held in Quebec City, Canada, on 3 October 1988. Excerpta Medica, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

J, Catalona William, Coffey Donald S, Karr James P, and Organ Systems Program (National Cancer Institute). Prostate Cancer Working Group., eds. Clinical aspects of prostate cancer: Assessment of new diagnostic and management procedures : proceedings of a workshop of the Prostate Cancer Working Group of the National Cancer Institute's Organ Systems Program, held October 16-19, 1988, at Prout's Neck, Maine, U.S.A. Elsevier, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

International Workshop on Diagnostic Ultrasound of the Prostate (1st 1988 Washington, D.C.). Diagnostic ultrasound of the prostate: Proceedings of the First International Workshop on Diagnostic Ultrasound of the Prostate, held October 22 through 23, 1988, in Washington, D.C. Edited by Resnick Martin I, Watanabe Hiroki 1935-, Karr James P, and International Workshop on Diagnostic Ultrasound of the Prostate (1st : 1988 : Washington, D.C.). Elsevier, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

1930-, Lee Fred, and McLeary Richard D, eds. The Use of transrectal ultrasound in the diagnosis and management of prostate cancer: Proceedings of a meeting held in Detroit, Michigan, September 11-12, 1986. Liss, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Prostate – Cancer – Diagnostic"

1

Milojević, Bogomir. "Diagnostic Approaches of Prostate Cancer: When Is a Biopsy Required?" In Prostate Cancer. Springer Nature Switzerland, 2024. http://dx.doi.org/10.1007/978-3-031-51712-9_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Savic-Radojevic, Ana, and Marija Pljesa-Ercegovac. "Diagnostic, Prognostic and Theranostic Potential of miRNAs in Prostate Cancer." In Prostate Cancer. Springer Nature Switzerland, 2024. http://dx.doi.org/10.1007/978-3-031-51712-9_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Goonewardene, Sanchia S., Peter Pietrzak, and David Albala. "Diagnostic Pathway for Prostate Cancer." In Basic Urological Management. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-98720-0_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ahmad, Mohammad Kaleem, Soumya Srivastava, and Abbas Ali Mahdi. "Molecular Diagnostic in Prostate Cancer." In Molecular Diagnostics in Cancer Patients. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-5877-7_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sobecki, Piotr, Rafał Jóźwiak, and Ihor Mykhalevych. "Performance of Deep CNN and Radiologists in Prostate Cancer Classification: A Comparative Pilot Study." In Digital Interaction and Machine Intelligence. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-37649-8_9.

Full text
Abstract:
AbstractIn recent years multiple deep-learning solutions have emerged that aim to assist radiologists in prostate cancer (PCa) diagnosis. Most of the studies however do not compare the diagnostic accuracy of the developed models to that of radiology specialists but simply report the model performance on the reference datasets. This makes it hard to infer the potential benefits and applicability of proposed methods in diagnostic workflows. In this paper, we investigate the effects of using pre-trained models in the differentiation of clinically significant PCa (csPCa) on mpMRI and report the results of conducted multi-reader multi-case pilot study involving human experts. The study aims to compare the performance of deep learning models with six radiologists varying in diagnostic experience. A subset of the ProstateX Challenge dataset counting 32 prostate lesions was used to evaluate the diagnostic accuracy of models and human raters using ROC analysis. Deep neural networks were found to achieve comparable performance to experienced readers in the diagnosis of csPCa. Results confirm the potential of deep neural networks in enhancing the cognitive abilities of radiologists in PCa assessment.
APA, Harvard, Vancouver, ISO, and other styles
6

Chang, Sam S., Neil H. Bander, and Warren D. W. Heston. "Biology of PSMA As a Diagnostic and Therapeutic Target." In Management of Prostate Cancer. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-776-5_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bard, Robert L. "Diagnostic Ultrasound Imaging of the Prostate." In Image Guided Prostate Cancer Treatments. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-40429-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Woodrum, David A., Akira Kawashima, Krzysztof R. Gorny, and Lance A. Mynderse. "Targeted Prostate Biopsy and MR-Guided Therapy for Prostate Cancer." In Molecular & Diagnostic Imaging in Prostate Cancer. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-99286-0_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pagliarulo, Vincenzo. "Androgen Deprivation Therapy for Prostate Cancer." In Molecular & Diagnostic Imaging in Prostate Cancer. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-99286-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Giannico, Giovanna A., and Omar Hameed. "Evaluation of Prostate Needle Biopsies." In Molecular & Diagnostic Imaging in Prostate Cancer. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-99286-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Prostate – Cancer – Diagnostic"

1

Chernorotov, Vladimir Alekseyevich, Victor Sergeyevich Kostenich, and Roman Romanovich Zvegintsev. "LANDMARKS AND MODERN APPROACHES IN PROSTATE CANCER DIAGNOSIS." In Themed collection of papers from Foreign international scientific conference «Joint innovation - joint development». Part 2. by HNRI «National development» in cooperation with PS of UA. October 2023. - Harbin (China). Crossref, 2024. http://dx.doi.org/10.37539/231024.2023.39.48.008.

Full text
Abstract:
The article describes the main landmarks of prostate cancer diagnostics development. Current morbidity and mortality rates in the Russian Federation and the world are given, the tendencies of prostate cancer morbidity increase are noted. The authors of the article have done the work on systematisation and characterisation of modern diagnostic methods with their critical evaluation.
APA, Harvard, Vancouver, ISO, and other styles
2

Satish, Pranav, Alex Freeman, Daniel Kelly, et al. "Prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: A systematic review and meta-analysis." In VIRTUAL ACADEMIC SURGERY CONFERENCE 2021. Cambridge Medicine Journal, 2021. http://dx.doi.org/10.7244/cmj.2021.04.001.2.

Full text
Abstract:
Introduction The implications of tumour location on mpMRI conspicuity are not fully understood. Identifying topographical correlates that influence conspicuity may improve outcomes. Here, we present the first systematic review and meta-analysis describing the effect of tumour location on prostate cancer conspicuity on mpMRI. Methods Medline, PubMed, EMBASE and Cochrane databases were systematically searched and results were assessed as per the PRISMA statement. Differential tumour conspicuity on mpMRI was compared between cancers in the peripheral zone (PZ), transitional zone (TZ), base, apex,
APA, Harvard, Vancouver, ISO, and other styles
3

King, Jason B., Sanidhya D. Tripathi, Mengkun Chen, et al. "Hydrogel surface enhanced Raman spectroscopy sensor for monitoring prostate cancer." In Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XXII, edited by Caroline Boudoux and James W. Tunnell. SPIE, 2024. http://dx.doi.org/10.1117/12.3002752.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Firjani, Ahmad, Adel Elmaghraby, and Ayman El-Baz. "MRI-based diagnostic system for early detection of prostate cancer." In 2013 Biomedical Sciences and Engineering Conference (BSEC). IEEE, 2013. http://dx.doi.org/10.1109/bsec.2013.6618490.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Reda, Islam, Ahmed Shalaby, Fahmi Khalifa, et al. "Computer-aided diagnostic tool for early detection of prostate cancer." In 2016 IEEE International Conference on Image Processing (ICIP). IEEE, 2016. http://dx.doi.org/10.1109/icip.2016.7532843.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Simon, Ronald, Martina Kluth, Kristine Fischer, et al. "Abstract 430: Prostate specific antigen (PSA) as a diagnostic and prognostic marker of prostate cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Simon, Ronald, Martina Kluth, Kristine Fischer, et al. "Abstract 430: Prostate specific antigen (PSA) as a diagnostic and prognostic marker of prostate cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kuzmenko, A. V., V. V. Kuzmenko, T. A. Giaurgiev, S. S. Menshikova, and D. E. Ukhin. "Diagnostic value of different research methods in patients with cancer prostate." In ТЕНДЕНЦИИ РАЗВИТИЯ НАУКИ И ОБРАЗОВАНИЯ. НИЦ «Л-Журнал», 2018. http://dx.doi.org/10.18411/lj-04-2018-114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Behr, Madeline, Shams Halat, Andrew Sholl, L. Spencer Krane, and J. Quincy Brown. "Real time diagnosis and mapping of ablative margins for prostate cancer using rapid on-site microscopy." In Bio-Optics: Design and Application. Optica Publishing Group, 2023. http://dx.doi.org/10.1364/boda.2023.dm4a.6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tripathi, Sanidhya D., Jason B. King, Mengkun Chen, et al. "Evaluation of prostate cancer biosensor using Raman spectroscopy for remote monitoring applications." In Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XXII, edited by Caroline Boudoux and James W. Tunnell. SPIE, 2024. http://dx.doi.org/10.1117/12.3002021.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Prostate – Cancer – Diagnostic"

1

Benny, Paul. Diagnostic and Therapeutic Radiopharmaceutical Agents for Selective Discrimination of Prostate Cancer. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada484303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gardiner, Robert A., and Martin F. Lavin. Development of a Novel, Non-Invasive Diagnostic Test for Prostate Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada499854.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bishopric, Nanette H. Novel Biomarker Discovery for Diagnostic and Therapeutic Strategies in Prostate Cancer. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada612044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Benny, Paul. Diagnostic and Therapeutic Radiopharmaceutical Agents for Selective Discrimination of Prostate Cancer. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada519205.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bishopric, Nanette H., and Betty Diamond. Novel Biomarker Discovery for Diagnostic and Therapeutic Strategies in Prostate Cancer. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada604489.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

O'Keefe, Denise S., and Warren D. Heston. Characterization of Prostate-Specific Membrane Antigen (PSMA) for Use in Therapeutic and Diagnostic Strategies Against Prostate Cancer. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada407353.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zeng, Jing, Meng Fan, Zeyu Xiao, Qingqing Cheng, Changzheng Shi, and Liangping Luo. Diagnostic ability of DCE-MRI for prostate cancer and clinically significant prostate cancer in equivocal lesions: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.9.0002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Alekseev, Oleg M. Expression of tNASP in Prostate Cancer: Opportunities for a Novel Diagnostic and Prognostic Biomarker Development. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada604609.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Menard, Cynthia. Integration of Diagnostic and Interventional MRI for the Study of Persistent Prostate Cancer after External Beam Radiotherapy. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada484277.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Menard, Cynthia. Integration of Diagnostic and Interventional MRI for the Study of Persistent Prostate Cancer After External Beam Radiotherapy. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada506560.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Prostate – Cancer – Diagnostic' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography